⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
SIRT6 Gene Delivery (AAV)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-05 — Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.: cross-connection with sirt6-activators: Both target SIRT6 restoration for aging phenotypes — MDL-800 as a small-molecule activator, AAV delivery as a genetic route; this finding adds a female-specific hepatic estrogen axis relevant to both. (novelty: 3)
- 2026-06-19 — Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.: AAV delivery of centenarian-variant SIRT6 raised SIRT6 protein and partially rescued senescence, genome instability, and progerin-stress phenotypes in progeria fibroblasts (animal-model / cell-based preclinical; no in vivo outcome data yet). [animal-model] (novelty: 4)
Open questions
Related
Contributing findings
Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.
19-jun-2026
novelty 4
per-area 4
strengthens